India is set to begin shipping the malaria drug hydroxychloroquine to the United States where President Donald Trump has touted it as a potential weapon against the coronavirus, Reuters has reported.
“The first shipments should start next week,” said Sudarshan Jain, secretary general of Indian Pharmaceutical Alliance (IPA).
India is the world’s largest producer of hydroxychloroquine but last month banned most exports to secure its own supplies, drawing warnings of retaliation from Trump.
